Characterization of a novel human anti-GD2 anti-idiotypic antibody GK8 DNA vaccine for immunotherapy in neuroblastoma

被引：0
|
作者：
Weixler, S. [1 ]
Fest, S. [1 ]
Huebener, N. [1 ]
Kruger, J. [1 ]
Gaedicke, G. [1 ]
Lode, H. [1 ]
机构：
[1] Charite Univ Med Berlin, Berlin, Germany
来源：
ACTA PAEDIATRICA | 2008年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [21] Survival of Neuroblastoma Patients in Countries with Limited Access to ANTI-GD2 Immunotherapy
    Yu, U.
    Xu, H.
    Chen, S.
    Yi, M.
    Liu, C.
    Liu, S.
    Yuan, X.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S216 - S216
  • [22] Treatment-Resistant Neuroblastoma Populations after Anti-GD2 Immunotherapy
    Zamora, Abigail K.
    Zobel, Michael J.
    Sun, Jianping
    Sheard, Michael A.
    Seeger, Robert C.
    Kim, Eugene S.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S217 - S217
  • [23] Bilateral tonic pupils secondary to anti-GD2 antibody therapy for neuroblastoma
    Edwards, Christopher M.
    Elefant, Daniel
    Isakoff, Michael S.
    Gaffar, Majida A.
    JOURNAL OF AAPOS, 2024, 28 (02):
  • [24] Dinutuximab: An Anti-GD2 Monoclonal Antibody for High-Risk Neuroblastoma
    Ploessl, Cady
    Pan, Alice
    Maples, Kathryn T.
    Lowe, Denise K.
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (05) : 416 - 422
  • [25] Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma
    Cheung, Irene Y.
    Cheung, Nai-Kong, V
    Modak, Shakeel
    Mauguen, Audrey
    Basu, Ellen
    Roberts, Stephen S.
    Ragupathi, Govind
    Kushner, Brian H.
    CANCER RESEARCH, 2020, 80 (16)
  • [26] Naxitamab: a humanized anti-glycolipid disialoganglioside (anti-GD2) monoclonal antibody for treatment of neuroblastoma
    Slatnick, L. R.
    Jimeno, A.
    Gore, L.
    Macy, M. E.
    DRUGS OF TODAY, 2021, 57 (11) : 677 - 688
  • [27] In Vivo Validation Of Trogocytosis In Neuroblastoma - A Potential Mechanism Of Resistance To Anti-GD2 Immunotherapy
    Zamora, Abigail K.
    Zobel, Michael J.
    Sun, Jianping
    Sheard, Michael
    Seeger, Robert
    Kim, Eugene S.
    PEDIATRICS, 2021, 147 (03)
  • [28] Outcome of Anti-GD2 Immunotherapy in Dutch Patients with High-Risk Neuroblastoma
    Tas, M.
    Dootjes, L.
    Fiocco, M.
    de Krijger, R.
    Dierselhuis, M.
    van Eijkelenburg, N.
    van Grotel, M.
    Kraal, K.
    Peek, A.
    van de Ven, K.
    de Keizer, B.
    Littooij, A.
    Janssens, G.
    Tytgat, G.
    van Noesel, M.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S341 - S342
  • [29] Boosting ADCP in neuroblastoma: manipulation of macrophages phenotype to enhance anti-GD2 immunotherapy
    Lanati, S.
    Chowdhury, F.
    Beers, S. A.
    Gray, J. C.
    IMMUNOLOGY, 2014, 143 : 137 - 138
  • [30] Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells
    Wu, Hong-Wei
    Sheard, Michael A.
    Malvar, Jemily
    Fernandez, G. Esteban
    DeClerck, Yves A.
    Blavier, Laurence
    Shimada, Hiroyuki
    Theuer, Charles P.
    Sposto, Richard
    Seeger, Robert C.
    CLINICAL CANCER RESEARCH, 2019, 25 (15) : 4761 - 4774
12345